PHARMACEUTICAL giant AstraZeneca has scrapped plans for a £450m (US$559m) upgrade to its vaccine manufacturing facility in ...

AstraZeneca has cancelled a multi-million pound investment in a vaccine plant in Merseyside because the government failed to ...

The NHS spring booster campaign will offer jabs to limited groups of vulnerable patients from 1 April. More than 9.7 million ...

Havant MP Alan Mak has accused the Labour Government of 'botching' a £450m investment deal with pharmaceutical giant ...

In particular, the charges have targeted two lawmakers typically seen as pharma foes: Sens. Bernie Sanders (I-Vt.) and ...

A planned investment deal between the Government and AstraZeneca is not going ahead because it did not “add up for the UK taxpayer”, science minister Sir Chris Bryant said.

It has been almost five years since the COVID-19 pandemic happened and close to two years since President Marcos lifted the ...

AstraZeneca’s Imfinzi (durvalumab) has received a positive recommendation from the European Medicines Agency’s Committee for Medicinal Produc ...

Invivyd, Inc. is a microcap biotech company focusing on antibody-based treatments for infectious diseases like COVID-19.

A Labour MP has stressed that "losing investment" in the north west "is not compensated for by investment in the Oxford to ...

Wall Street falls as Trump imposes tariffs, but not as badly as feared The threat of a punishing trade war sent Wall Street ...

As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...